bibliographicCitation |
Imai E, Chan JCN, Ito S, Yamasaki T, Kobayashi F, Haneda M, Makino H, for the ORIENT study investigators. Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study. Diabetologia. 2011 Oct 13;54(12):2978–86. doi: 10.1007/s00125-011-2325-z. |